Diane-35 + N-METHYL-N-ETHYLTRYPTAMINE for endometrial neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 7 Apr 2022: Trial registered, NCT05316935
  2. 13 Jul 2022: Trial started, NCT05316935

The trials

NCT05316935: GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients

State
Under way
Phase
Phase 2 and Phase 3
People
80 planned
Started
13 Jul 2022
Primary completion
30 Mar 2028
Arms
Non-obese EEC group (D), Non-obese EAH group (D)
Results
None posted
  1. 7 Apr 2022: Trial registered
  2. 13 Jul 2022: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.